1997
EBV-associated Kikuchi's histiocytic necrotizing lymphadenitis with cutaneous manifestations
Yen A, Fearneyhough P, Raimer S, Hudnall S. EBV-associated Kikuchi's histiocytic necrotizing lymphadenitis with cutaneous manifestations. Journal Of The American Academy Of Dermatology 1997, 36: 342-346. PMID: 9039215, DOI: 10.1016/s0190-9622(97)80413-6.Peer-Reviewed Original ResearchConceptsHistiocytic necrotizing lymphadenitisKikuchi's histiocytic necrotizing lymphadenitisNecrotizing lymphadenitisCutaneous manifestationsSkin lesionsAtypical lymphoid cellsEBER-1 RNACrusted papulesLymph nodesMalignant lymphomaPathologic findingsKaryorrhectic debrisSerologic studiesPatchy necrosisHistiocytic aggregatesSpontaneous resolutionImmunoperoxidase stainingLymphoid cellsLymphadenitisCausative agentLesionsEBVSitu hybridizationManifestationsMyalgia
1992
Fulminant Epstein‐Barr virus‐associated post‐transplant lymphoproliferative disorders following OKT3 therapy
Canfield C, Hudnall S, Colonna J, Busuttil R, Wilkinson A, Danovitch G, Shaked A, Goldstein L, Rosenthal J. Fulminant Epstein‐Barr virus‐associated post‐transplant lymphoproliferative disorders following OKT3 therapy. Clinical Transplantation 1992, 6: 1-9. DOI: 10.1111/j.1399-0012.1992.tb00580.x.Peer-Reviewed Original ResearchPost-transplant lymphoproliferative disorderLymphoproliferative disordersEpstein-Barr virus-associated post-transplant lymphoproliferative disorderAssociated with Epstein-Barr virusOKT3 monoclonal antibody therapySequelae of immunosuppressionWithdrawal of immunosuppressionMonoclonal antibody therapyPeripheral blood smearEpstein-Barr virusOKT3 therapyAtypical lymphocytesMalignant lymphomaAntibody therapyClinical spectrumProphylactic useImmunosuppressionOKT3Medical CenterBlood smearsAcyclovirTherapyDisordersLymphomaLymphocytes
1987
Role of CD8+ and CD8- Cytolytic Effectors in IL2 Reversal of Cyclosporin-Inhibited EBV-B-Cell Cytotoxicity
Hudnall S, Kurbe M. Role of CD8+ and CD8- Cytolytic Effectors in IL2 Reversal of Cyclosporin-Inhibited EBV-B-Cell Cytotoxicity. Experimental Biology And Medicine 1987, 513-515. DOI: 10.1007/978-1-4612-4590-2_110.Peer-Reviewed Original ResearchEpstein-Barr virusPeripheral blood mononuclear cellsRecombinant interleukin-2Interleukin-2B cellsAutologous Epstein-Barr virusB95-8 Epstein-Barr virusRole of CD8NK cell cytotoxicityOrgan transplant recipientsBlood mononuclear cellsForm of cytotoxicityReactivation infectionTransplant recipientsSuppressor/Effector phenotypeMalignant lymphomaCytolytic effectorsMononuclear cellsT cellsCell cytotoxicityCyclosporin ADrug cyclosporin ACsACytotoxicity